MedQuist welcomed back to Nasdaq

TriMed Staff | | Health Imaging | Screening

The Nasdaq Stock Market has approved MedQuist’s application for listing on its Global Market. The company has been trading on the pink sheets since 2004. 

The Mount Laurel, N.J.-based company said its stock will begin trading on the Global Market under the ticker symbol MEDQ.    

“We are pleased to announce the company’s listing on the Nasdaq Global Market. We believe that Nasdaq will provide our investors with a more transparent electronic market to aid their trading efficiency and liquidity needs,” said Mark Ivie, MedQuist’s interim president and CEO.

In December 2007, MedQuist cut 10 percent of its workforce in an effort to reduce operating expenses and realign its expenditures, allowing the company to regain cash flow.

 

TriMed Staff

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.